drugset / Trial / NCT00359944
Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate efficacy and safety of different doses of AC-3933 in patients with mild to moderate Alzheimer's Disease.
Timeline
- Start
- 2006-02
- Primary completion
- 2008-09
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RESEQUINIL | Small molecule | 5 mg | — |
| Subject | RESEQUINIL | Small molecule | 20 mg | — |